Barclays PLC Increases Stock Holdings in Quipt Home Medical Corp. (NASDAQ:QIPT)

Barclays PLC boosted its position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT) by 79.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,425 shares of the company’s stock after purchasing an additional 38,635 shares during the period. Barclays PLC owned approximately 0.20% of Quipt Home Medical worth $256,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Hsbc Holdings PLC increased its holdings in shares of Quipt Home Medical by 10.4% during the 2nd quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock worth $165,000 after buying an additional 4,969 shares during the last quarter. State Street Corp increased its stake in Quipt Home Medical by 1.0% during the third quarter. State Street Corp now owns 621,388 shares of the company’s stock worth $1,814,000 after acquiring an additional 6,317 shares during the last quarter. Rhumbline Advisers raised its position in Quipt Home Medical by 21.0% in the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after purchasing an additional 8,541 shares during the period. Jane Street Group LLC lifted its stake in shares of Quipt Home Medical by 28.5% in the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock valued at $122,000 after purchasing an additional 9,290 shares during the last quarter. Finally, ProShare Advisors LLC acquired a new position in shares of Quipt Home Medical in the 2nd quarter valued at $35,000. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Stock Up 3.1 %

Shares of NASDAQ:QIPT opened at $3.02 on Tuesday. The company has a market capitalization of $130.13 million, a price-to-earnings ratio of -20.13 and a beta of 0.56. Quipt Home Medical Corp. has a 12-month low of $2.30 and a 12-month high of $4.99. The business has a 50-day moving average price of $2.73 and a 200 day moving average price of $2.89. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.73.

Quipt Home Medical (NASDAQ:QIPT) last announced its earnings results on Monday, December 16th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.08). Quipt Home Medical had a negative return on equity of 6.18% and a negative net margin of 2.66%. Sell-side analysts expect that Quipt Home Medical Corp. will post -0.15 EPS for the current year.

Insider Activity at Quipt Home Medical

In other news, VP Patrick Dennis Gamble bought 17,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 26th. The shares were purchased at an average price of $2.45 per share, with a total value of $41,650.00. Following the purchase, the vice president now owns 40,057 shares in the company, valued at approximately $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 4.20% of the stock is owned by insiders.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.